Glass Jacobson Investment Advisors LLC Viking Therapeutics, Inc. Transaction History
Glass Jacobson Investment Advisors LLC
- $302 Billion
- Q3 2024
A detailed history of Glass Jacobson Investment Advisors LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Glass Jacobson Investment Advisors LLC holds 375 shares of VKTX stock, worth $19,496. This represents 0.01% of its overall portfolio holdings.
Number of Shares
375
Previous 375
-0.0%
Holding current value
$19,496
Previous $19.9 Million
19.43%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
474Shares Held
66.2MCall Options Held
5.72MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$529 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$313 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$243 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$110 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$97.5 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.99B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...